Neptune Technologies & Bioressources Inc.
500 St. Martin Boulevard, Suite 550
Laval
Quebec
H7M 3Y2
Canada
Tel: 888-664-9166
Website: http://www.neptunebiotech.com/
69 articles about Neptune Technologies & Bioressources Inc.
-
Neptune Receives Confirmation of Readiness Letter from Health Canada
9/17/2018
Key milestone toward approval of application to become a Licensed Producer achieved
-
Neptune Announces Appointment of Hélène F. Fortin to its Board of Directors
8/16/2018
Hélène F. Fortin FCPA, FCA, ICD.D-IAS.A has been practicing public accounting for more than 30 years
-
Neptune Announces the Election of its Directors and Voting Results
8/15/2018
Neptune Technologies & Bioressources Inc. announces the voting results for the matters listed in its management proxy circular dated July 17, 2018 held at its Annual and Special Meeting of Shareholders in Montreal, Canada on August 15, 2018 (the "AGM").
-
Neptune Announces First Quarter of 2018 Results
8/14/2018
Phase I Investment of the Cannabis Business Plan Completed And Phase II capacity expansion ongoing
-
Neptune Files Two Patent Applications for Innovative Cannabis Extraction Processes
8/9/2018
Neptune Technologies & Bioressources Inc. has filed two applications with the United States Patent and Trademark Office (USPTO) for patents related to the extraction of cannabis material.
-
Neptune Announces Multi-year Agreement with Canopy Growth to Provide Extracted Cannabis Products
6/19/2018
Neptune Technologies & Bioressources Inc. announced that it entered into a multi-year agreement with Canopy Growth
-
Neptune Announces Fourth Quarter and Year-end Results
6/5/2018
Neptune Technologies & Bioressources Inc. announced its financial and operating results for the 3-month and 12-month periods ended March 31, 2018.
-
Neptune and Tetra Bio-Pharma Enter Co-Development Agreement for Purified Cannabinoid Oil-Based Products targeting Pain and Inflammation
2/12/2018
Neptune and Tetra Bio-Pharma announced that they entered into an agreement for the co-development, commercialization and marketing of purified cannabinoid oil-based products to address pain and inflammation relief applications for the natural health products and pet veterinary markets.
-
Neptune Receives Nasdaq Notification Confirming that it has Regained Compliance with Minimum Bid Requirements
11/30/2017
Neptune, announces that on November 28, 2017 it received notification from Nasdaq Listing Qualifications Department confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) - bid price.
-
Neptune Technologies & Bioressources Inc. Announces Appointments For Its Cannabis Business
10/2/2017
-
Neptune Technologies & Bioressources Inc. To Hold Conference Call To Discuss First Quarter Results For The Three Months Period Ended June 30, 2017
7/25/2017
-
Neptune Technologies & Bioressources Inc. Enters Into Commercial Distribution Joint Venture In China With Shanghai Chonghe Marine Industry Co., Ltd.
4/6/2017
-
Neptune Technologies & Bioressources Inc. Announces Preliminary Q3 Results
12/7/2015
-
Neptune Technologies & Bioressources Inc Provides Business Update
11/6/2015
-
Neptune Technologies & Bioressources Inc. To Hold Conference Call to Discuss Second Quarter Results
9/23/2015
-
Mario Paradis Appointed CFO Of Neptune Technologies & Bioressources Inc. And Acasti Pharma
8/6/2015
-
Neptune Technologies & Bioressources Inc. Announces First Quarter Results
7/14/2015
-
U.S. Patent Trial And Appeal Board Upholds Original Decision In Neptune Technologies & Bioressources Inc.'s Favour
7/10/2015
-
Neptune Technologies & Bioressources Inc. To Hold Conference Call To Discuss First Quarter Results
6/29/2015
-
Neptune Technologies & Bioressources Inc. Announces New Board Of Director Nominees For Election At Annual And Special Meeting Of Shareholders
5/28/2015